Association of single nucleotide polymorphisms (SNPs)of PADI4 gene with rheumatoid arthritis (RA)in Indian population

Genes and Genetic Systems

Volumn 87, Issue 3, 2012, Pages 191-196

  Panati, Kalpana ^a   Pal, Sarvajeet ^b   Rao, K V ^a   Reddy, Vudem D ^a  

^a OSMANIA UNIVERSITY   (India)

^b Advance Rheumatology Clinic   (India)

Author keywords

Anti CCP antibodies; PADI4; Rheumatoid arthritis; SNP

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GENOMIC DNA; PROTEIN ANTIBODY; RHEUMATOID FACTOR; RHEUMATOID FACTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DNA EXTRACTION; EXON; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PADI4 GENE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPE;

ARTHRITIS, RHEUMATOID; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84867909608     PISSN: 13417568     EISSN: 18805779     Source Type: Journal    
DOI: 10.1266/ggs.87.191     Document Type: Article

References (30)

1. Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315-324.
2. Barton, A., Jury, F., Eyre, S., Bowes, J., Hinks, A., Ward, D., and Worthington, J. (2004a) Haplotype analysis in simplex families and novel analytic approaches in a case-control cohort reveal no evidence of association of the CTLA-4 gene with rheumatoid arthritis. Arthritis Rheum. 50, 748-752.
3. Barton, A., Bowes, J., Eyre, S., Spreckley, K., Hinks, A., John, S., and Worthington. J. (2004b) A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum. 50, 1117-1121.
4. Bas, S., Genevay, S., Meyer, O., and Gabay, C. (2003) Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford) 42, 677-680.
5. Chen, R., Wei, Y., Cai, Q., Duan, S., Ren, D., Shen, J., He, D., Fang, M., Lv, K, Cheng, N., et al. (2011) The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population. Rheumatol. Int. 31, 1631-1634.
6. Chen, S. Y., Wan, L., Huang, C. M., Huang, Y. C., Sheu, J. J., Lin, Y. J., Liu, S. P., Lan, Y. C., Lai, C. H., Lin, C. W., et al. (2010) Genetic polymorphisms of the DNA repair gene MPGmay be associated with susceptibility to rheumatoid arthritis. J. Appl. Genet. 51, 519-521.
7. Cornelis, F., Faure, S., Martinez, M., Prud'homme, J. F., Fritz, P., Dib, C., Alves, H., Barrera, P., de Vries, N., Balsa, A., et al. (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc. Natl. Acad. Sci. USA 95, 10746-10750.
8. Deighton, C. M., Walker, D. J., Griffiths, I. D., and Roberts, D. F. (1989) The contribution of HLA to rheumatoid arthritis. Clin. Genet. 36, 178-182.
9. Dubucquoi, S., Solau-Gervais, E., Lefranc, D., Marguerie, L., Sibilia, J., Goetz, J., Dutoit, V., Fauchais, A. L., Hachulla, E., Flipo, R. M., et al. (2004) Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann. Rheum. Dis. 63, 415-419.
10. Fan, L. Y., Wang, W. J., Wang, Q., Zong, M., Yang, L., Zhang, H., Sun, L. S., Lu, T. B., and Han, J. (2008) A functional haplotype and expression of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Chinese. Tissue Antigens 72, 469-473.
11. Gandjbakhch, F., Fajardy, I., Ferre, B., Dubucquoi, S., Flipo, R. M., Roger, N., and Solau-Gervais, E. (2009) A functional haplotype of PADI4 gene in rheumatoid arthritis: Positive correlation in a French population. J. Rheumatol. 36, 881-886.
12. Gupta, R., Thabah, M. M., Aneja, R., Kumar, A., Varghese, T., and Chandrasenan, P. J. (2009) Usefulness of anti-CCP antibodies in rheumatic diseases in Indian patients. Indian. J. Med. Sci. 63, 92-100.
13. Hochberg, M. C., and Spector, T. D. (1990) Epidemiology of rheumatoid arthritis: update. Epidemiol. Rev. 12, 247-252.
14. Hoppe, B., Haupl, T., Gruber, R., Kiesewetter, H., Burmester, G. R., Salama, A., and Dorner, T. (2006) Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res. Ther. 8, R34.
15. Kang, C. P., Lee, H. S., Ju, H., Cho, H., Kang, C., and Bae, S. C. (2006) A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum. 54, 90-96.
16. Lahiri, D. K., and Nurnberger, J. I., Jr. (1991) A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19, 5444.
17. MacGregor, A. J., Snieder, H., Rigby, A. S., Koskenvuo, M., Kaprio, J., Aho, K., and Silman, A. J. (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 43, 30-37.
18. Martinez, A., Valdivia, A., Pascual-Salcedo, D., Lamas, J. R., Fernandez-Arquero, M., Balsa, A., Fernandez-Gutierrez, B., de la Concha, E. G., and Urcelay, E. (2005) PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology (Oxford) 44, 1263-1266.
19. Meyer, O., Labarre, C., Dougados, M., Goupille, P., Cantagrel, A., Dubois, A., Nicaise-Roland, P., Sibilia, J., and Combe, B. (2003) Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann. Rheum. Dis. 62, 120-126.
20. Nijenhuis, S., Zendman, A. J., Vossenaar, E. R., Pruijn, G. J., and van Venrooij, W. J. (2004) Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin. Chim. Acta. 350, 17-34.
21. Onder, B., Kurtaran, A., Kimyon, S., Selcuk, B., and Akyuz, M. (2009) Association of anti-CCP positivity with serum ferritin and DAS-28. Rheumatol. Int. 30, 223-227.
22. Serdaroglu, M., Cakirbay, H., Deger, O., Cengiz, S., and Kul, S. (2008) The association of anti-CCP antibodies with disease activity in rheumatoid arthritis. Rheumatol. Int. 28, 965-970.
23. Suzuki, A., Yamada, R., Chang, X., Tokuhiro, S., Sawada, T., Suzuki, M., Nagasaki, M., Nakayama-Hamada, M., Kawaida, R., Ono, M., et al. (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34, 395-402.
24. Utz, P. J., Genovese, M. C., and Robinson, W. H. (2004) Unlocking the "PAD" lock on rheumatoid arthritis. Ann. Rheum. Dis. 63, 330-332.
25. Vallbracht, I., and Helmke, K. (2005) Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Autoimmun. Rev. 4, 389-394.
26. Van Venrooij, W. J., Hazes, J. M., and Visser, H. (2002) Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth. J. Med. 60, 383-388.
27. Vossenaar, E. R., Zendman, A. J., van Venrooij, W. J., and Pruijn, G. J. (2003) PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25, 1106-1118.
28. Wener, M. H., Hutchinson, K., Morishima, C., and Gretch, D. R. (2004) Absence of antibodies to cyclic citrullinated peptide in sera of patients with hepatitis C virus infection and cryoglobulinemia. Arthritis Rheum. 50, 2305-2308.
29. Yamada, R., and Yamamoto, K. (2007) Mechanisms of disease: genetics of rheumatoid arthritis--ethnic differences in disease-associated genes. Nat. Clin. Pract. Rheumatol. 3, 644-650.
30. Zhang, C., Wang, Y., Chen, H., Lan, X., and Lei, C. (2007) Enhance the efficiency of single-strand conformation polymorphism analysis by short polyacrylamide gel and modified silver staining. Anal. Biochem. 365, 286-287.